Brief: FDA To Review Two Modified Risk Tobacco Product Renewal Applications From 22nd Century Group
12/05/2026 18:25
May 12 (Reuters) - FDA: FDA: FILED TWO MODIFIED RISK TOBACCO PRODUCT RENEWAL APPLICATIONS FOR SCIENTIFIC REVIEW FROM 22ND CENTURY GROUP Further company coverage: XXII.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on 22nd Century
See all newsCigarette maker 22nd Century Group's Q3 revenue rises on Pinnacle same-store growth
Brief: 22nd Century Group Q3 Revenue USD 4.8 Million
Brief: 22Nd Century Same Store Unit Sales For Pinnacle Vln® And Pinnacle Pure Surge 161%
Brief: 22Nd Century Group Urges FDA To Enact Nicotine Yield Standard For Cigarettes
NASDAQ RESUMED AT 01:10 PM